HomeEmployersMineralystherapeutics
M

Mineralystherapeutics

greenhouse
373 open positions
Last updated Jul 23, 2026
Remote100%
Hybrid0%
On-site0%
Salary shown97%
Avg. listing45d
This month309 new · 0 closed
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Detroit

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
1 0 0 1mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Denver

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
1 0 0 1mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Dallas

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
0 0 0 1mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Columbus

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
1 0 0 1mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Chicago

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
2 0 0 1mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Charlotte

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
0 0 0 1mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Regional Sales Director - Atlanta

$180k–$215k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherRegional Sales DirectorExecutive
See 2 similar>
0 0 0 1mo ago
M
Mineralystherapeutics·US Remote ·Remote · Worldwide

Director, Statistical Programming

$235k–$248k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherDirectorExecutive
See 2 similar>
0 0 0 1mo ago
M
Mineralystherapeutics·US Remote ·Remote · Worldwide

Senior Medical Director

$330k–$364k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherDirectorMedical DirectorSenior
See 3 similar>
0 0 0 1mo ago
M
Mineralystherapeutics·US Remote ·Remote · Worldwide

Manager/Sr. Manager - Digital Center of Excellence

$140k–$157k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OperationsOtherProject ManagerDigitalMid
See 4 similar>
4 0 0 2mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Executive Director, Clinical Development

$340k–$370k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherExecutive DirectorExecutive
See 2 similar>
4 0 0 3mo ago
M
Mineralystherapeutics·US Remote·Remote · Worldwide

Marketing Coordinator

$80k–$95k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

OtherMarketing CoordinatorAdministration & Office SupportMeeting CoordinatorMid
See 4 similar>
3 0 0 3mo ago
M
Mineralystherapeutics·US Remote ·Remote · Worldwide

Senior Counsel – Compliance

$250k–$285k/year
43
Low

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product

Legal & ComplianceOtherComplianceSenior
See 3 similar>
5 0 0 3mo ago